Further research is needed to develop effective treatments and improve outcomes for patients with RP2-associated RP. We have established the InsightRP2 consortium, a multidisciplinary research project that incorporates clinical data, AI-supported imaging analysis and experimental disease modelling to facilitate the development of a targeted gene therapy for RP2-associated retinitis pigmentosa. For more information, visit our website https://www.insight-rp2.org or contact us at insight.rp2@med.uni-goettingen.de.
RP2